English
Choose your country/region and language
Your experience may change as only information for the country or region you select will be presented.
Todd W. Kelley
Dr. Kelley received M.S. and M.D. degrees from Ohio State University followed by Residency and Fellowship training at the Cleveland Clinic. He is board certified in Anatomic and Clinical Pathology and Hematology. Previously he was a tenured Associate Professor of Pathology at the University of Utah and Medical Director of Hematopathology and Co-scientific Director of Next Generation Sequencing and Biocomputing at ARUP Laboratories. Prior to joining Beckman Coulter, he was laboratory director and head of scientific affairs at Navican Genomics, an oncology-focused genomic testing laboratory started by Intermountain Healthcare. He has published over 70 research articles, reviews and book chapters and is active in many professional societies including the Association for Molecular Pathology and the American Society of Hematology.
Articles
Convalescent Plasma: The Hope of Liquid Gold
As we race to find a way to treat COVID-19 and await an effective vaccine, plasma therapy shows promise. Read more.
Acute MI Detection with a High-sensitivity Cardiac Troponin Assay
Overburdened EDs must triage patients quickly. See how next-generation troponin assays streamline care for a vast number of patients presenting with chest pain.
Delayed Sepsis Diagnosis: Patient Perspectives
For patients with or at risk of developing sepsis, every minute matters. Learn about promising research to aid in early sepsis detection.
